Central Asian University (CAU) recently hosted a highly anticipated guest lecture on “Enterprising Ophthalmology,” featuring ELZA’s CEO and CMO, Nikki and Farhad Hafezi.
Exploring comprehensive keratoconus treatment, from cross-linking to surgery, in the highly respected scientific journal Nature Reviews.
Corneal Physician reports on ELZA’s exploration of slit-lamp CXL as a promising, accessible treatment for infectious keratitis.
Prof. Farhad Hafezi from the ELZA Institute provided an insightful update on the Second Global Consensus on Keratoconus during an interview with EyeTube.
In a recently published case report in American Journal of Ophthalmology Case Reports, our team, in collaboration with Brazilian colleagues, describes an unusual case of a “CTK-like syndrome” following sequential intracorneal ring segment (ICRS) implantation and corneal cross-linking (CXL) in a young patient with progressive keratoconus.
Prof. Hafezi presents Femto-CAIRS and high fluence cross-linking, highlighting its advantages for keratoconus treatment and improving visual outcomes
Innovations in Corneal Cross-Linking (CXL): A Look at 25 Years of Progress
The AAO-ESCRS Joint Symposium, convened leading ophthalmology experts to explore the latest developments in CXL.
Monday, September 9 is the last day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons.
Sunday, September 8th is the third day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons.
